231 related articles for article (PubMed ID: 25193624)
21. Screening active anti-breast cancer compounds from Cortex Magnolia officinalis by 2D LC-MS.
Hou X; Yuan X; Zhang B; Wang S; Chen Q
J Sep Sci; 2013 Feb; 36(4):706-12. PubMed ID: 23401389
[TBL] [Abstract][Full Text] [Related]
22. Effects of neolignans from the stem bark of Magnolia obovata on plant pathogenic fungi.
Choi NH; Choi GJ; Min BS; Jang KS; Choi YH; Kang MS; Park MS; Choi JE; Bae BK; Kim JC
J Appl Microbiol; 2009 Jun; 106(6):2057-63. PubMed ID: 19245403
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial and cytotoxic activities of neolignans from Magnolia officinalis.
Syu WJ; Shen CC; Lu JJ; Lee GH; Sun CM
Chem Biodivers; 2004 Mar; 1(3):530-7. PubMed ID: 17191867
[TBL] [Abstract][Full Text] [Related]
24. Neolignans from North American Magnolia species with cyclooxygenase 2 inhibitory activity.
Schühly W; Khan SI; Fischer NH
Inflammopharmacology; 2009 Apr; 17(2):106-10. PubMed ID: 19214385
[TBL] [Abstract][Full Text] [Related]
25. Induction of apoptosis in human leukemia cell (Jurkat) by neolignans isolated from seeds of Licaria puchury-major.
Uchiyama T; Tabata K; Nomura S; Kaneko Y; Fujimoto Y; Suzuki T
Biol Pharm Bull; 2009 Oct; 32(10):1749-53. PubMed ID: 19801838
[TBL] [Abstract][Full Text] [Related]
26. In Vitro and In Silico Studies of Neolignans from
Pandey P; Kumarihamy M; Chaturvedi K; Ibrahim MAM; Lambert JA; Godfrey M; Doerksen RJ; Muhammad I
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770918
[No Abstract] [Full Text] [Related]
27. Cytotoxic lignans from the stems of Herpetospermum pedunculosum.
Ma Y; Wang H; Wang R; Meng F; Dong Z; Wang G; Lan X; Quan H; Liao Z; Chen M
Phytochemistry; 2019 Aug; 164():102-110. PubMed ID: 31112925
[TBL] [Abstract][Full Text] [Related]
28. Production of honokiol and magnolol in suspension cultures of Magnolia dealbata Zucc.
Domínguez F; Chivez M; Garduñ-Ramírez ML; Chávez-Avila VM; Mata M; Cruz-Sosa F
Nat Prod Commun; 2009 Jul; 4(7):939-43. PubMed ID: 19731598
[TBL] [Abstract][Full Text] [Related]
29. Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells.
Park EJ; Min HY; Chung HJ; Hong JY; Kang YJ; Hung TM; Youn UJ; Kim YS; Bae K; Kang SS; Lee SK
Cancer Lett; 2009 May; 277(2):133-40. PubMed ID: 19135778
[TBL] [Abstract][Full Text] [Related]
30. Facile purification of honokiol and its antiviral and cytotoxic properties.
Amblard F; Delinsky D; Arbiser JL; Schinazi RF
J Med Chem; 2006 Jun; 49(11):3426-7. PubMed ID: 16722664
[TBL] [Abstract][Full Text] [Related]
31. Antioxidant and cytotoxic lignans from the roots of Bupleurum chinense.
Li DQ; Wang D; Zhou L; Li LZ; Liu QB; Wu YY; Yang JY; Song SJ; Wu CF
J Asian Nat Prod Res; 2017 May; 19(5):519-527. PubMed ID: 27649745
[TBL] [Abstract][Full Text] [Related]
32. Magnolol suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting Ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways.
Kim KM; Kim NS; Kim J; Park JS; Yi JM; Lee J; Bang OS
Nutr Cancer; 2013; 65(8):1245-53. PubMed ID: 24066970
[TBL] [Abstract][Full Text] [Related]
33. Studies on inhibitors of skin tumor promotion, IX. Neolignans from Magnolia officinalis.
Konoshima T; Kozuka M; Tokuda H; Nishino H; Iwashima A; Haruna M; Ito K; Tanabe M
J Nat Prod; 1991; 54(3):816-22. PubMed ID: 1659613
[TBL] [Abstract][Full Text] [Related]
34. Honokiol analogs: a novel class of anticancer agents targeting cell signaling pathways and other bioactivities.
Kumar A; Kumar Singh U; Chaudhary A
Future Med Chem; 2013 May; 5(7):809-29. PubMed ID: 23651094
[TBL] [Abstract][Full Text] [Related]
35. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
[TBL] [Abstract][Full Text] [Related]
36. Anti-inflammatory effect of 4-O-methylhonokiol, compound isolated from Magnolia officinalis through inhibition of NF-kappaB [corrected].
Oh JH; Kang LL; Ban JO; Kim YH; Kim KH; Han SB; Hong JT
Chem Biol Interact; 2009 Aug; 180(3):506-14. PubMed ID: 19539808
[TBL] [Abstract][Full Text] [Related]
37. Differential proteomic analysis of HeLa cells treated with Honokiol using a quantitative proteomic strategy.
Ling B; Liang SF; Xu YH; Zhao XY; Tang MH; Liu XY; Zhao X; Huang CH; Chen LJ; Wei YQ
Amino Acids; 2008 Jun; 35(1):115-22. PubMed ID: 18157584
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxic sesquiterpenoids from the leaves of Magnolia grandiflora.
Ding LF; Su J; Pan ZH; Zhang ZJ; Li XN; Song LD; Wu XD; Zhao QS
Phytochemistry; 2018 Nov; 155():182-190. PubMed ID: 30145456
[TBL] [Abstract][Full Text] [Related]
39. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.
Rajendran P; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Ahn KS; Kumar AP; Sethi G
J Cell Physiol; 2012 May; 227(5):2184-95. PubMed ID: 21792937
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial activity and cytotoxic effects of Magnolia dealbata and its active compounds.
Jacobo-Salcedo Mdel R; Gonzalez-Espindola LA; Alonso-Castro AJ; Gonzalez-Martinez Mdel R; Domínguez F; Garcia-Carranca A
Nat Prod Commun; 2011 Aug; 6(8):1121-4. PubMed ID: 21922914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]